Novel therapies to enhance anti-tumour immunity [ 2018 - 2021 ]

Research Grant

[Cite as]

Researchers: Dr Jane Oliaro (Principal investigator) ,  Dr David Gyorki A/Pr Ilia Voskoboinik

Brief description Immunotherapy is a new approach to treat cancer, and works by promoting the immune system to attack cancer. Immunotherapies, such as checkpoint blockade and adoptive T cell therapy, are proving to be very successful in certain human cancers. However, combining immunotherapy with drugs that cause cancer cell death may be more effective. This project will investigate the potential of combining immunotherapy with a novel anti-cancer drug, in order to develop more effective treatments for cancer.

Funding Amount $AUD 808,767.40

Funding Scheme Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Viewed: [[ro.stat.viewed]]